Robert L Giuntoli II, M.D.
Professor of Clinical Obstetrics and Gynecology
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Director, Gynecologic Oncology, Chester County Hospital, West Chester, PA
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending , Department of Surgery, Children's Hospital of Philadelphia, PA
Department: Obstetrics and Gynecology
Contact information
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
10th Floor South
Philadelphia, PA 19104
3400 Civic Center Blvd.
10th Floor South
Philadelphia, PA 19104
Office: 800-789-7366
Education:
B.A. (Biology)
University of Pennsylvania, Philadelphia, PA, 1990.
M.D.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
Permanent linkB.A. (Biology)
University of Pennsylvania, Philadelphia, PA, 1990.
M.D.
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
Selected Publications
Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian DA, Rodriguez D, Smith SA, Dean E, Domchek SM, Drapkin R, Shih IM, Brown EJ, Hwang WT, Armstrong DK, Gaillard S, Giuntoli R, Simpkins F: Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer. Clin Cancer Res 29(15):2800-2807, Aug 2023.Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli II RL, Kim S, Simpkins F: Molecular profiling of mucinous ovarian carcinoma reveals actionable mutations and a unique genomic profile. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL Mar 2023.
Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, Kim SH, Giuntoli II RL: Non-operative management of clinical early-stage endometrioid endometrial carcinoma: hormonal or radiation therapy? (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL Mar 2023.
Nasioudis D, Gysler S, Ko E, Cory L, Giuntoli II R, Kim S, Latif N: Next generation sequencing reveals distinct molecular subgroups of endometrioid ovarian carcinoma. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL Mar 2023.
Nasioudis D, Gysler S, Latif NA, Ko EM, Cory L, Kim SH, Cliby WA, Giuntoli II RL: High rates of neo-adjuvant chemotherapy use in high-risk advanced stage epithelial ovarian carcinoma is associated with improved outcomes. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL Mar 2023.
Nasioudis D, Gysler S, Latif N, Ko E, Cory L, Giuntoli R, Kim S, Simpkins F: Prevalence of ESR1 gene mutations in gynecologic malignancies with high-estrogen receptor expression. (Poster) 54th Society of Gynecologic Oncology annual meeting, Tampa, FL Mar 2023.
Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal SJ: Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. Natl Compr Canc Netw 21(2):181-209, Feb 2023.
Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Simpkins F, Morgan MA, Giuntoli RL 2nd: Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma. Gynecol Oncol 169:41-46, Feb 2023.
Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Simpkins F, Ko EM: Molecular landscape of EBBR2/HER2 gene amplification among patients with endometrial carcinoma. Featured Poster International Gynecologic Cancer Society Meeting, New York Sep 2022.
Nasioudis D, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA: Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes. Am J Clin Oncol 45(9):373-378, Sep 2022.